# Enliven Therapeutics, Inc.: Form SC 13D/A, filed Feb 2, 2024

- Company: [Enliven Therapeutics, Inc.](/companies/elvn.md) (CIK 1672619)
- Form: SC 13D/A
- Filed: 2024-02-02
- Accepted by EDGAR: Feb 2, 2024, 16:15 ET
- Period: not reported
- Accession: 0001104659-24-010043
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1672619/000110465924010043/tm245036d1_sc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1672619/000110465924010043/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1672619/000110465924010043/tm245036d1_sc13da.htm

Filed Feb 2, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-010043. Last ingested by Listed: Nov 5, 2026, 17:49 ET. No prices; not investment advice.